Jonathan P. Schneck, MD, PhD (he/him/his)

Professor
Johns Hopkins University, United States

Disclosure information not submitted.

Presentation(s):

• Modulating T cell phenotype and expansion via alternating co-stimulatory molecule ratio on a functional hydrogel

  Thursday, October 24, 2024
  1:45 PM – 2:00 PM EST

• Using nanoparticles as artificial antigen presenting cells to activate human CD4 T cells for immunotherapy

  Thursday, October 24, 2024
  2:30 PM – 2:45 PM EST

• Poster CC12 - Elucidating the Impacts of Shape and Stiffness on CD8+ T cell Activation Using Particulate Artificial Antigen Presenting Cells

  Thursday, October 24, 2024
  2:45 PM – 3:45 PM EST

• Poster N12 - Investigating Co-Activation of CD4+ and CD8+ T-cells Using an Artificial Lymph Node

  Friday, October 25, 2024
  10:00 AM – 11:00 AM EST

• Poster CC14 - Investigating the mechanism and immunomodulatory effects of IL-7 potentiation by a neutralizing anti-cytokine monoclonal antibody

  Friday, October 25, 2024
  10:00 AM – 11:00 AM EST

• Poster CC17 - Lymph node-mimicking hydrogels presenting dual co-stimulation modulate T cell phenotype and anti-tumor function in vivo

  Friday, October 25, 2024
  10:00 AM – 11:00 AM EST

• Engineering A Biomaterials-based Lymphoid Niche for mRNA Lipid Nanoparticle Cancer Vaccines

  Friday, October 25, 2024
  2:45 PM – 3:00 PM EST

• Poster C4 - Polymeric artificial antigen presenting cells for CD8+ T cell activation and phenotypic skewing

  Friday, October 25, 2024
  3:30 PM – 4:30 PM EST

• Poster T4 - Using RT-qPCR as an Early Screening Method for Antigen Specific CD4 T Cell Activation

  Saturday, October 26, 2024
  10:00 AM – 11:00 AM EST